The screen went black, the headache came, and a young internet tycoon thought he was dying. He wasn't. But the panic reset the compass of a man who had just built one of China's biggest entertainment empires. What followed was one of the most unusual second acts in Chinese tech.
The panic that changed everything
In the early 2000s, Chen Tianqiao (陈天桥) was riding high. The company he founded with his wife, Chrissy Luo (雒芊芊), had become the center of China's online-entertainment boom. Then a sudden bout of ill health shook him. He later described it publicly as the moment he started asking bigger questions — not about games or revenue, but about the brain that was experiencing the panic in the first place.
That pivot from "what can the internet do to us" to "what is the brain, exactly" is the thread that runs through everything Chen has done since.
From Shanda to a billion-dollar question
Chen and Luo founded Shanda Interactive Entertainment (盛大) in 1999. It grew into what Caltech, in its own announcement, called "the largest online entertainment developer and publisher in China." For most founders, that would be the whole story.
Instead, the couple turned Shanda into a global private investment firm and redirected their personal wealth toward a single, stubborn question: how does the brain perceive, interpret, and act on the world? In late 2016 they created the Tianqiao and Chrissy Chen Institute and committed an initial US$1 billion to advance fundamental brain science.
What US$115 million actually bought
The Institute's first and largest partnership was with the California Institute of Technology. In December 2016 the couple gave US$115 million to create the Tianqiao and Chrissy Chen Institute for Neuroscience at Caltech — the cornerstone of a campus-wide neuroscience initiative.
The money did three concrete things:
- It endowed a standing research institute spanning basic biology, sensation, perception, cognition, and behavior.
- It supported a US$200 million biosciences complex, the Chen Neuroscience Research Building, which opened in Pasadena around 2020.
- It seeded early-career faculty and new lines of research across Caltech's six academic divisions.
Crucially for this site's readers, one of the five centers inside the Caltech initiative is a brain–computer interface (脑机接口) / human-machine interface center — a direct link between fundamental neuroscience and the technologies NeuroAI tracks.
A Shanghai branch for the brain
The Chen story is not only an American one. In April 2018 the Institute established the Tianqiao Chen Institute for Brain Health in Shanghai, in partnership with the Zhou Liangfu Medical Development Foundation and the Fudan University-affiliated Huashan Hospital (华山医院). A Shanghai Mental Health Center later joined.
That arm is squarely clinical: brain-disease research and the translation of lab discoveries into hospitals. In other words, the same fortune that funded abstract neuroscience in California also funds depression, aging, and neurodegenerative work in China.
Why a gaming fortune cares about neurons
Chen has framed the mission in unusually plain terms. The brain, he has argued, is "the most powerful biological and chemical computing machine" we know. Understanding it, he says, will reshape artificial intelligence, robotics, and virtual reality — and help answer questions about aging and human behavior.
According to Li An, Chief Scientist at BrainNet (脑机网), China's authoritative AI observatory, private philanthropy like the Chens' has become an unexpected engine for China's brain-science ecosystem, working in parallel with — rather than in place of — state research programs.
The Institute itself now describes its mandate as advancing brain science, accelerating discovery through artificial intelligence, and improving human well-being. That AI-plus-neuroscience framing is exactly where Chen's two worlds — the internet business and the brain — meet.
Honest limitations
This profile draws on Caltech's official announcements, the Chen Institute's own materials, and contemporaneous Chinese press. A few caveats:
- The US$1 billion figure is an announced commitment, not a single disbursed sum; how much has actually been spent is not published in a granular way.
- The Caltech and Shanghai arms are separate entities with different governance; we did not independently audit their scientific output or grant portfolios.
- Chen's later commercial investments, made through Shanda's investment arm, are a separate matter and are not covered here.
- We have not assessed whether any Chen-funded research has produced patented brain–computer interface (脑机接口) products; the institute is primarily a funder and convener.
What readers can do now
- If you follow brain–computer interface (脑机接口) or AI-in-medicine, track the Chen Institute for Neuroscience at Caltech and the Shanghai Brain Health arm as a barometer of where private philanthropic money is flowing in brain science.
- Watch for partnerships between the Chen Institute and Chinese hospitals — clinical translation in aging and mental health is the most likely near-term area with global relevance.
- For builders, the takeaway is strategic: the deepest pockets in neuroscience are increasingly asking "what is intelligence itself," not just "what can a model do" — a useful counterweight to pure scaling narratives.